Business
Tetra Bio-Pharma Inc. Announces Changes to its Board of Directors and the Filing of a Supplement to its Management Information Circular
Tetra Bio-Pharma Inc. Announces Changes to its Board of Directors and the Filing of a Supplement to its Management Information Circular.
About this update from Tetra Bio-pharma Inc.
[{"type":"text","content":"\n\n\n\nTetra Bio-Pharma Inc. Announces Changes to its Board of Directors and the Filing of a Supplement to its Management Information Circular\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTetra Bio-Pharma Inc. Announces Changes to its Board of Directors and the Filing of a Supplement to its Management Information Circular\nCanada NewsWire\nOTTAWA, ON, May 18, 2021\n\n\n\nOTTAWA, ON, May 18, 2021 /CNW Telbec/ - Tetra Bio-Pharma Inc. (\"Tetra\" or the \"Company\") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, wishes to announce changes to its board of directors (the \"Board\") and the filing of a supplement to its management information circular dated April 20, 2021 (the \"Circular\") filed on SEDAR under the Company's profile at www.sedar.com. \nThe Company wishes to announce that two additional nominees will be proposed for election as directors at the upcoming annual and special meeting of shareholders of the Company scheduled to be held on May 28, 2021 (the \"Meeting\"), and management wishes to announce its support for the election of Ms. Catherine Auld and Mr. John Kim as directors of the Company. The Board believes that the addition of these two nominees will enhance the overall skill set of the Board given their relevant industry expertise.\nMr. John Kim – Mr. Kim is an independent business consultant, investor, and director of both public and private companies and has extensive experience in capital markets. He is passionate about helping entrepreneurs grow their businesses, especially in the areas of technology and healthcare, and currently advises several startups in Canada.  Mr. Kim is a director of WELL Health Technologies Corp, a TSX listed company, where he chairs the Governance and Compensation Committee.  He is also a director of EMERGE Commerce Ltd., a TSX Venture listed company, where he chairs the Audit Committee. Previously, Mr. Kim was an award-winning Portfolio Manager whose career spanned over 20 years, managing mutual funds, hedge funds, and private cli...